Hematology – Featured
Join us at the 2026 Mayo Clinic Classical Hematology Conference: Nonmalignant Hematology and Bleeding and Thrombotic Disorders, where innovation, collaboration, and expertise come together to advance the field of hematology.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss the Protecting Access to Medicare Act (PAMA) and a recent Cyclospora outbreak making headlines. Later, Dr. Pritt welcomes Juliana Perez Botero, M.D., a Mayo Clinic hematologist, to explore innovative testing approaches for bleeding disorders.
We are excited to announce that registration is now open for the 2026 Mayo Clinic Classical Hematology Conference: Nonmalignant Hematology and Bleeding and Thrombotic Disorders.
Christopher Garcia, M.D., shares how secure digital tools, wearable data, and AI can enable more personalized diagnostic pathways, while still keeping clinicians in the driver’s seat.
A young dancer from Minnesota thrives with a rare blood disorder, thanks to resilience, family advocacy, and lifesaving lab medicine.
Early and accurate detection of heparin-induced thrombocytopenia (HIT) and thrombotic thrombocytopenic purpura (TTP) is critical to improving patient outcomes. The following podcast episodes feature expert[...]
At this year's Classical Hematology Conference we will be joined by Hematology experts, Adam Cuker, M.D. and Stephan Moll, M.D. Reserve your spot today.
Registration is now open for the 2025 Mayo Clinic Classical Hematology Conference: Nonmalignant Hematology and Bleeding and Thrombotic Disorders. Reserve your spot today.
Mayo Clinic researchers identify a new subtype of MGTS, linked to recurrent blood clots, with significant diagnostic challenges and treatment implications.
Dr. Dong Chen and Dr. Sounak Gupta joined the “Becker’s Healthcare Podcast” to discuss the molecular testing space and its important role in personalized cancer treatment. Dr. Chen and Dr. Gupta highlighted the importance of selecting the right molecular tests for patients, the impact of genetic testing on cancer diagnosis and treatment, and how Mayo Clinic Laboratories is helping physicians make informed decisions for the best patient outcomes.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Dong Chen, M.D., Ph.D., chair of the Division of Hematopathology in the Department of Laboratory Medicine and Pathology at Mayo Clinic. They discuss rare and inherited platelet disorders and esoteric laboratory testing of hematologic disorders.
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., interviews Ewa Wysokinska, M.D., an assistant professor of medicine and consultant in the division of hematology and oncology at Mayo Clinic in Florida, to talk about clinical updates in thrombotic thrombocytopenic purpura.
David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the syndrome, which severely impacts multiple organs and blood.